You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 135 No. 2, February 2009 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Head & Neck Cancer
 •Neoplasms of Head & Neck
 •Drug Therapy
 •Drug Therapy, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Suppression of Interleukin 6 and 8 Production in Head and Neck Cancer Cells With Curcumin via Inhibition of I{kappa}β Kinase

Alen N. Cohen, MD; Mysore S. Veena, PhD; Eri S. Srivatsan, PhD; Marilene B. Wang, MD

Arch Otolaryngol Head Neck Surg. 2009;135(2):190-197.

Objectives  To evaluate the effect of curcumin on production of interleukin 6 (IL-6) and 8 (IL-8) in head and neck squamous cell carcinoma (HNSCC) cell lines and to determine the mechanism by which these effects are modulated. Curcumin suppression of HNSCC is believed to be partly due to inhibition of the transcription factor nuclear factor-{kappa}β (NF-{kappa}β). Interleukin 6 and IL-8 are cytokines induced by NF-{kappa}β activation with elevated levels in the serum of patients with HNSCC.

Design  We treated HNSCC cell lines CCL23, CAL27, UM-SCC1, and UM-SCC14A with increasing doses of curcumin and measured IL-6 and IL-8 levels using an enzyme-linked immunosorbent assay.

Setting  Levels of NF-{kappa}β, I{kappa}β kinase (IKK), and phosphorylated I{kappa}β were analyzed by means of Western blot. The IKK activity was measured in UM-SCC14A cells using an IKK-specific I{kappa}β{alpha} substrate after treatment with curcumin.

Main Outcome Measures  Reverse transcription–polymerase chain reaction was performed to determine the effect of curcumin on the expression of IL-6 and IL-8.

Results  Curcumin treatment resulted in dose-dependent inhibition of IL-6 and IL-8 in all cell lines. All cell lines had similar NF-{kappa}β levels; however, UM-SCC1 and UM-SCC14A had significantly higher I{kappa}β kinase levels and required considerably higher doses of curcumin before inhibition of IL-6 and IL-8 occurred. Curcumin treatment resulted in inhibition of IKK activity and inhibition of IL-6 and IL-8 expression.

Conclusions  Curcumin significantly reduces IL-6 and IL-8 levels in HNSCC cell lines. This mechanism appears to be mediated via inhibition of I{kappa}β-kinase activity in the NF-{kappa}β pathway. Interleukins 6 and 8 have potential use as biomarkers to measure the efficacy of treatment with curcumin.


Author Affiliations: Division of Head and Neck Surgery (Drs Cohen and Wang), Department of Surgery (Drs Veena and Srivatsan), David Geffen School of Medicine, University of California, Los Angeles, and Department of Surgery, Veterans Affairs Greater Los Angeles Healthcare System (Drs Veena, Srivatsan, and Wang).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2009 American Medical Association. All Rights Reserved.